Michael Wang: Mechanisms of Senescence‑Associated Drug Resistance in Lymphoma

Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center shared on X:

“A review in International Journal of Oncology discusses mechanisms of senescence‑associated drug resistance in lymphoma and highlights emerging strategies using senolytics, which are drugs designed to specifically target senescent cells.”

Read further.
Source: Michael Wang/X